| 1. | The treatment of refractory depression with mirtazapine
米氮平治疗难治性抑郁症的初步观察 |
| 2. | Effect of mirtazapine in patients with anorexia nervosa
米氮平治疗神经性厌食症的疗效对照研究 |
| 3. | The control study of mirtazapine in treating the patients with panic disorder
米氮平治疗惊恐障碍患者对照研究 |
| 4. | Mirtazapine compared with paroxetine in depressed patients with anxiety symptoms
米氮平与帕罗西汀治疗伴有焦虑症状抑郁症的对照研究 |
| 5. | Comparative study of citalopram vs mirtazapine in treatment of senile depressive patients
西酞普兰与米氮平治疗老年抑郁症的对照研究 |
| 6. | Mirtazapine and fluoxetine in the treatment of cardiovascular neurosis with depression
米氮平和氟西汀治疗伴抑郁的心血管神经症的临床观察 |
| 7. | A comparative study between mirtazapine and buspirone in the treatment of generalized anxiety disorder
米氮平和丁螺环酮治疗广泛性焦虑症的对照研究 |
| 8. | Curative effects of mirtazapine in protracted withdrawal syndrome of patients with heroin dependence
米氮平治疗海洛因依赖患者稽延性戒断症状的疗效观察 |
| 9. | Mirtazapine ' s more rapid effect is prominent on all symptoms of depression especailly on anxiety - somatization , retardation and sleep disturbance
瑞美隆更迅速的起效作用在抑郁症的各个症状均有突出表现，尤其是焦虑-失眠，迟滞和睡眠障碍。 |
| 10. | Mirtazapine was prepared by a seven - step reaction , namely nucleophilic ring - opening reaction , chlorination , cyclization , uncleophilic substitution , hydrolysis , reduction and cyclization from styrene oxide and n - methylethanolamine as the starting materials , with overall yield of 22 . 6 %
摘要以环氧苯乙烯和n -甲基乙醇胺为起始原料，经亲核开环、氯代和环合反应得到中间体1 -甲基3 -苯基哌嗪。 |
